Kelly Financial Services’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,000
| Closed | -$16.9K | – | 160 |
|
|
2024
Q2 | $16.9K | Hold |
4,000
| – | – | 0.01% | 351 |
|
|
2024
Q1 | $20.4K | Hold |
4,000
| – | – | 0.01% | 322 |
|
|
2023
Q4 | $37.2K | Hold |
4,000
| – | – | 0.02% | 235 |
|
|
2023
Q3 | $26.2K | Hold |
4,000
| – | – | 0.01% | 251 |
|
|
2023
Q2 | $32.5K | Hold |
4,000
| – | – | 0.02% | 237 |
|
|
2023
Q1 | $34.3K | Hold |
4,000
| – | – | 0.02% | 220 |
|
|
2022
Q4 | $37K | Hold |
4,000
| – | – | 0.02% | 204 |
|
|
2022
Q3 | $41.3K | Hold |
4,000
| – | – | 0.02% | 171 |
|
|
2022
Q2 | $40K | Hold |
4,000
| – | – | 0.02% | 185 |
|
|
2022
Q1 | $49.2K | Hold |
4,000
| – | – | 0.02% | 179 |
|
|
2021
Q4 | $69.4K | Hold |
4,000
| – | – | 0.03% | 146 |
|
|
2021
Q3 | $71.8K | Sell |
4,000
-87,440
| -96% | -$1.57M | 0.04% | 131 |
|
|
2021
Q2 | $4M | Buy |
91,440
+88,440
| +2,948% | +$3.87M | 0.15% | 38 |
|
|
2021
Q1 | $44.9K | Buy |
3,000
+2,800
| +1,400% | +$41.9K | 0.03% | 134 |
|
|
2020
Q4 | $1.08K | Buy |
+200
| New | +$1.08K | ﹤0.01% | 508 |
|